Announcements Trials
Browse Landscape

Phase

Phase 2 34Phase NA 19Phase 1 18Phase 1/2 13Phase 3 5Phase 4 2

Status

Completed 11Unknown 4Terminated 2Not yet recruiting 2Active not recruiting 2Withdrawn 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Breast Neoplasms 7Prostatic Neoplasms 6Papillomavirus Infections 6Neoplasms 6Polycystic Ovary Syndrome 3Colorectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Tuberous Sclerosis 2Thyroid Neoplasms 2Stomach Neoplasms 2Smoking Cessation 2Sarcoma 2Rectal Neoplasms 2Pancreatic Neoplasms 2Multiple Myeloma 2Leukemia, Myeloid, Acute 2Hematologic Neoplasms 2Head and Neck Neoplasms 2Graft vs Host Disease 2Dupuytren Contracture 2Diabetes Mellitus 2Dementia 2Cardiovascular Diseases 2Carcinoma, Hepatocellular 2Wrist Fractures 1Vaccine-Preventable Diseases 1Uterine Cervical Neoplasms 1Tobacco Use Cessation 1Thyroid Diseases 1Thalassemia 1

Interventions

Hydromorphone 1Human Papillomavirus Recombinant Vaccine nonavalent 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Active not recruiting × Hematologic Neoplasms × Clear all
NCT03023631 2026-05-20

Gardasil 9 Vaccine in Preventing HPV Infection in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

M.D. Anderson Cancer Center

Phase 4 Active not recruiting
48 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT04296305 2025-12-26

Effect of Opioid Infusion Rate on Abuse Liability Potential of Intravenous Hydromorphone for Cancer Pain

M.D. Anderson Cancer Center

Phase 4 Active not recruiting
84 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡